The Impact of Innovation Input and Output on IPO Pricing and Long-term Performance --Evidence from the Bio-Pharmaceutical Industry in China

Chao Chen,Haoping Xu
2019-01-01
Abstract:Employing data from bio-pharmaceutical new issuers in China, this paper studies the different impacts of innovation inputs and output on initial public offering (IPO) pricing in an emerging market. Six types of information are employed and two indices are constructed to measure innovation input and output. The results show that these two dimensions play different roles in IPO pricing. Innovation output contributes to both the relative issuing and trading prices as well as the IPO first-day return while innovation input plays a weak (if any) role in IPO pricing. The two dimensions can enhance each other when input and output are both higher. They both contribute to increase five-year post-IPO market performance, giving supports to that both innovation input and output are undervalued at stage of IPOs.
What problem does this paper attempt to address?